Breast; Flashcards
Which population does mammary duct ectasia typically present in? [1]
What is another major risk factor? [1]
Perimenopausal women
Smoking is significant RF
Fibroadenoma - how / when do you treat? [1]
If >3cm surgical excision is usual, Phyllodes tumours should be widely excised (mastectomy if the lesion is large)
How do you treat a breast cyst? [2]
- Cysts should be aspirated
- Those which are blood stained or persistently refill should be biopsied or excised
[] occur in women that are lactating (producing breast milk), often after stopping breastfeeding
Galactoceles occur in women that are lactating (producing breast milk), often after stopping breastfeeding
Describe what a galactocele is [1]
Where/how do they usually occur? [1]
They are breast milk filled cysts that occur when the lactiferous duct is blocked, preventing the gland from draining milk
They present with a firm, mobile, painless lump, usually beneath the areola.
Where does breast cancer met. to? [4]
Metastasis – 2B2L = brain, bones, lung, liver
How do you treat a phyllodes tumour? [1]
Treatment involves surgical removal of the tumour and the surrounding tissue (“wide excision”). They can reoccur after removal
Describe the difference between cyclical and non-cyclical breast pain
Cyclical breast pain:
- is more common and is related to hormonal fluctuations during the menstrual cycle.
- The pain typically occurs during the two weeks BEFORE menstruation (the luteal phase) and settles during the menstrual period.
- There may be other symptoms of premenstrual syndrome, such as low mood, bloating, fatigue or headaches.
Non-Cyclical Breast Pain:
- Non-cyclical breast pain is more common in women aged 40 – 50 years
- It is more likely to be localised than cyclical breast pain. Often no cause is found. However, it may be caused by: Medications (e.g., hormonal contraceptive medications); Infection (e.g., mastitis); Pregnancy
Which is the most common type of breast cancer
Invasive ductal carcinoma.
Invasive lobular carcinoma
Ductal carcinoma-in-situ (DCIS)
Lobular carcinoma-in-situ (LCIS)
Which is the most common type of breast cancer
Invasive ductal carcinoma.
- This is the most common type of breast cancer. To complicate matters further this has recently been renamed ‘No Special Type (NST)’. In contrast, lobular carcinoma and other rarer types of breast cancer are classified as ‘Special Type’
Invasive lobular carcinoma
Ductal carcinoma-in-situ (DCIS)
Lobular carcinoma-in-situ (LCIS)
Describe the different types of surgery [2] for breast cancer and why they might be given to patients,
Give the reasons you would choose one / other [4]
Women either have a wide-local excision or a mastectomy:
- Around two-thirds of tumours can be removed with a wide-local excision.
Which surgeries can be provided for high risk breast cancer patients [2]]
Risk-reducing bilateral mastectomy or bilateral oophorectomy (removing the ovaries) is an option for women at high risk.
- This is suitable for only a small number of women and requires significant counselling and weighing up risks and benefits.
When is radiotherapy offered for breast cancer? [1]
- Whole breast radiotherapy is recommended after a woman has had a wide-local excision as this may reduce the risk of recurrence by around two-thirds.
- For women who’ve had a mastectomy radiotherapy is offered for T3-T4 tumours and for those with four or more positive axillary node
TOM TIP: What do you need to remember about a patient with breast cancer who has had axillary clearance (if they were re-emitted) [1]
TOM TIP: It is important to remember that you should avoid taking blood or putting a cannula in the arm on the side of previous breast cancer removal surgery. This is because there is a higher risk of complications and infection due to the impaired lymphatic drainage on that side.
Gene Expression Profiling
Gene expression profiling involves assessing which genes are present within the breast cancer on a histology sample. This helps predict the probability that the breast cancer will reoccur as a distal metastasis (away from the original cancer site) within 10 years.
The NICE guidelines (2018) [DG34] recommend this for which breast cancers? [1]
Gene Expression Profiling
Gene expression profiling involves assessing which genes are present within the breast cancer on a histology sample. This helps predict the probability that the breast cancer will reoccur as a distal metastasis (away from the original cancer site) within 10 years.
The NICE guidelines (2018) [DG34] recommend this for women with early breast cancers that are ER positive but HER2 and lymph node negative. It helps guide whether to give additional chemotherapy.